Remote Patient Monitoring Integrated with iVisit Telehealth Solution Launches

Remote Patient Monitoring Solution Launches

GenieMD, Inc. (“GenieMD”), GenieMD, provider of a HIPAA-compliant, cloud-based, mobile-first virtual care services platform, supporting several different care engagement modalities is announcing the official launch of their Remote Patient Monitoring solution – which is integrated with their globally deployed iVisit Telehealth solution.

“Now IPAs, ACOs, self-ensured employers, healthsystems and payers can adopt one platform to integrate with their delivery of care model,” said Thomas Foley, Chief Growth Officer, of GenieMD.

GenieMD, previously recognized as “The Most Innovative Telemedicine Solution Provider” now provides a complete end-to-end virtual care platform, inclusive of telehealth, remote patient monitoring and call triage services. Most often the iVisit virtual care services platform is white-labeled to advance the presence of our clients in their respective communities.  GenieMD further integrates computing platform, medical devices and medical carts, including the global logistics necessary to get remote patient monitoring kits to the targeted patient – resulting in a full end-to-end, one stop virtual care solution. This approach mitigates risks and further reduces costs to maximize utilization of limited financial resources.

“Given our experience with GenieMD* iVisit Telehealth platform and testing the robust features of the RPM services, there is very high confidence it will further enhance the delivery of care model across our community of care.” said, Dr. Juan Ramos, Chief Executive Officer, of Tu Salud Virtual.

“GenieMD’s iVisit virtual care solution portfolio facilitates innovative approach to delivery of care,” said Dr. Soheil Saadat, Chief Executive Officer, of GenieMD. “The iVisit portfolio coupled with the rich integration of medical devices allows our physicians to expand services to remotely monitoring patient across several chronic disease states.

*Based in San Francisco, CA, GenieMD, Inc. is an award-winning, global provider of telemedicine, remote patient monitoring and clinical call center triage solutions. GenieMD offers customized white-labeled telehealth solutions to hospitals, health networks, large group practices and commercial insurance carriers. Its enterprise clients are based throughout the United States as well as in Europe, Asia and South America. Maximizing the potential of cloud computing, big data, artificial intelligence and mobile technologies, GenieMD is transforming health care to provide the best and fastest care to patients when they need it most. GenieMD is Legitscript-approved, having met the highest standards for legality, safety and transparency. 

SourceGenieMD

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”